Filing Flows › HealthLynked (HLYK) › Q2 2026 › vs Q1 2026
HealthLynked (HLYK) Q2 2026 vs Q1 2026 (quarter over quarter)
HealthLynked's revenue fell $174K (-41%) from $423K in Q1 2026 to $250K in Q2 2026. The biggest changes: Patient service revenue, net −$188K (-45%); Product revenue +$11K (+793%); Subscription revenue +$4K (+106%).
HealthLynked, Q2 2026: revenue $250K (-58% year over year), operating margin -215.7%, net loss $820K, operating cash flow −$350K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Patient service revenue, net | $231K | $419K | −$188K | -45% |
| Product revenue | $12K | $1K | $11K | +793% |
| Subscription revenue | $7K | $3K | $4K | +106% |
| Revenue | $250K | $423K | −$174K | -41% |
| Net loss | $820K | $1.6M | −$802K | -49% |
| Costs & expenses | $1.1M | $2.0M | −$975K | -48% |
| Operating costs | $789K | $1.1M | −$336K | -30% |
| Interest & other, net | $281K | $920K | −$640K | -69% |
| SG&A | $517K | $847K | −$330K | -39% |
| Other operating costs | $271K | $277K | −$6K | -2% |
| Operating cash sources | $820K | $1.6M | −$802K | -49% |
| Depreciation | $10K | $26K | −$16K | -61% |
| Share-based compensation | $88K | $298K | −$209K | -70% |
| Working capital & other | $371K | $1.1M | −$705K | -66% |
| Cash used in operations | $350K | $222K | $128K | +58% |
| Net loss absorbed | $820K | $1.6M | −$802K | -49% |
Questions
How much did HealthLynked's revenue grow quarter over quarter in Q2 2026?
HealthLynked's revenue fell $174K (-41%) from $423K in Q1 2026 to $250K in Q2 2026.
What drove HealthLynked's revenue change in Q2 2026?
Patient service revenue, net −$188K (-45%); Product revenue +$11K (+793%); Subscription revenue +$4K (+106%).